Amgen (AMGN) total debt

Total debt · fiscal 2025
$54.60B

Amgen (AMGN) carried total debt of $54.60B at the end of fiscal 2025 (December 31, 2025). That is 9.1% lower than the $60.10B of fiscal 2024. Figures as of 18 Nov 2026, 06:23 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$54.60B
Change on fiscal 2024
−9.1%
Growth, 5 years
+10.6% a year
Growth, 10 years
+5.7% a year
Highest on record
$64.61Bfiscal 2023
Lowest on record
$10.60Bfiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Amgen total debt, in more detail

Over the five fiscal years to 2025 total debt grew at a compound 10.6% a year; over ten years the rate was 5.7% a year. Across the 17 fiscal years on record (2009–2025), the highest was $64.61B in fiscal 2023 and the lowest $10.60B in fiscal 2009.

Total debt was 6.3× shareholders' equity at the end of fiscal 2025.

History · 17 fiscal years

Total debt by fiscal year

Amgen total debt, year by year

Amgen (AMGN) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$54.60B 9.1% down6.3×
2024$60.10B 7.0% down10.2×
2023$64.61B 65.9% up10.4×
2022$38.95B 16.9% up10.6×
2021$33.31B 1.0% up5.0×
2020$32.99B 10.3% up3.5×
2019$29.90B 11.9% down3.1×
2018$33.93B 4.0% down2.7×
2017$35.34B 2.2% up1.4×
2016$34.60B 10.1% up1.2×
2015$31.43B 2.3% up1.1×
2014$30.72B 4.4% down1.2×
2013$32.13B 21.1% up1.5×
2012$26.53B 23.8% up1.4×
2011$21.43B 60.4% up1.1×
2010$13.36B 26.0% up0.6×
2009$10.60B—0.5×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Amgen and comparable companies
CompanyTotal debtFiscal year
Novartis NVS$35.38B2025
AstraZeneca AZN$29.15B2025
Thermo Fisher Scientific TMO$39.39B2025
Amgen AMGN$54.60B2025
Gilead Sciences GILD$24.94B2025
Abbott Laboratories ABT$13.86B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on AMGN

Amgen, figure by figure

Amgen (AMGN) overview: price, valuation and scorecardAll health care companies by market value

Amgen total debt: questions and answers

How much debt does Amgen have?

Amgen (AMGN) carried total debt of $54.60B at the end of fiscal 2025 (December 31, 2025). That is 9.1% lower than the $60.10B of fiscal 2024.

What is the growth rate of Amgen's total debt?

Over the five fiscal years to 2025 total debt grew at a compound 10.6% a year; over ten years the rate was 5.7% a year.

What are the highest and lowest total debt figures on record for Amgen?

Across the 17 fiscal years on record (2009–2025), the highest was $64.61B in fiscal 2023 and the lowest $10.60B in fiscal 2009.

How does Amgen's debt compare with its equity?

Total debt was 6.3× shareholders' equity at the end of fiscal 2025.

How is Amgen's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amgen (AMGN) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/AMGN/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.